Radiopharmaceuticals - Global Strategic Business Report

New Therapeutic Radiopharmaceuticals to Drive Global Market

The global market for Radiopharmaceuticals is estimated at US$6.9 Billion in 2023 and is projected to reach US$14.3 Billion by 2030, growing at a CAGR of 11.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the radiopharmaceuticals market is driven by several factors. The increasing prevalence of cancer and cardiovascular diseases is a major driver, as these conditions require advanced diagnostic and therapeutic solutions. Technological advancements in imaging and radiopharmaceutical development are enhancing the accuracy and efficacy of nuclear medicine procedures. Regulatory support and streamlined approval processes are facilitating the introduction of new radiopharmaceuticals.

The growing adoption of personalized medicine is also boosting demand, as radiopharmaceuticals can be tailored to individual patient needs. Additionally, increasing investments in nuclear medicine research and the expansion of healthcare infrastructure are contributing to market growth. These factors collectively ensure the sustained growth and innovation in the radiopharmaceuticals market.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the SPECT Radioisotopes segment, which is expected to reach US$6.2 Billion by 2030 with a CAGR of a 10.4%. The PET Radioisotopes segment is also set to grow at 10.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $3.4 Billion in 2023, and China, forecasted to grow at an impressive 14.1% CAGR to reach $1.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Radiopharmaceuticals Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Radiopharmaceuticals Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Radiopharmaceuticals Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Actinium Pharmaceuticals, Inc., Advanced Accelerator Applications, Alliance Medical Ltd., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 141 Featured):

• Actinium Pharmaceuticals, Inc.
• Advanced Accelerator Applications
• Alliance Medical Ltd.
• Bayer HealthCare Pharmaceuticals
• Bracco Diagnostics, Inc.
• Cardinal Health, Inc.
• Curium US LLC
• GE Healthcare
• IBA Radiopharma Solutions
• Jubilant DraxImage Inc.
• Lantheus Medical Imaging Inc.
• Medi-Radiopharma Ltd.
• Nordion Inc.
• Radiopharm Theranostics Ltd.
• Siemens Healthcare GmbH